The ex-hedge-funder-turned-pharmaceutical-price-gouger made headlines this week when he raised the price Daraprim, a drug that treats life-threatening parasitic infections in AIDS patients, from $13.50 to $750 a tablet. (For the record: Each tablet only costs about $1 to produce.)
“It really doesn’t make sense to get any criticism for this,” Shkreli told the New York Times. “This isn’t the greedy drug company trying to gouge patients. It is us trying to stay in business.”
Over the past day or so, Shkreli seems to have been glued to his Twitter page, spewing off childish and snarky remarks at internet trolls and generally being an unapologetic little bitch.
But despite his overconfidence, it seems Shkreli may not be cut out for the long term role of supervillian, after all. He announced earlier today that he will be “flipping my Twitter to private” after receiving an endless string of nasty comments. Evidently, he can’t take the heat as well as he dishes it, though he claims it’s because he is “busy” with his “important job” coming up with the next group of patients to price gouge.
After abandoning Twitter, here’s to hoping he abandons his evil business practices as well. We are not holding our breath.
Scroll down to read some of what he’s been saying on Twitter, which we screen grabbed. (Seriously, someone needs to get this dude a publicist ASAP!)…